Telephone-Based Care Coordination for Services Addressing Childhood Adversity

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Health Services; Mental Health; Well-being Interventions: Behavioral: Telephone-based Screening and Care Coordination Sponsors: Paul Chung; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); University of California,...

Clinical Efficacy and Safety of Jingfang Granules in Treating Diarrhea-Predominant Irritable Bowel Syndrome With Cold-Dampness Disturbing Spleen Syndrome

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Diarrhea-predominant Irritable Bowel Syndrome Interventions: Drug: Trimebutine Maleate Tablets; Drug: Jingfang Granules Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting Conditions: Diarrhea-predominant Irritable Bowel...

Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Gastric Cancer; Colorectal Cancer; Breast Cancer; Cervical Cancer; Head and Neck Cancer (H&N) Interventions: Drug: First-line immunotherapy (immune checkpoint inhibitors), INVIMA-approved, standard of care Sponsors: Centro de Tratamiento e...

Simultaneous T2-FLAIR and T1 Brain MRI With ENRAGED FLAIR in Multiple Sclerosis

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Multiple Sclerosis Interventions: Diagnostic Test: ENRAGED FLAIR MRI Sponsors: Region Stockholm Not yet recruiting Conditions: Multiple Sclerosis Interventions: Diagnostic Test: ENRAGED FLAIR MRI Sponsors: Region Stockholm Not yet...

Sacituzumab Tirumotecan Plus Immunotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Recurrent or Metastatic Head and Neck Carcinoma Interventions: Drug: Sacituzumab Tirumotecan Plus Immune Checkpoint Inhibitor Sponsors: Biying Chen Not yet recruiting Conditions: Recurrent or Metastatic Head and Neck Carcinoma Interventions: Drug:...

Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules – DRC

by palligoelme@gmail.com | Jul 7, 2026 | Clinical Trials

​ Conditions: Ebola Hemorrhagic Fever Interventions: Diagnostic Test: DECIPHER bioassay Sponsors: Institute of Tropical Medicine, Belgium; Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo Not yet recruiting Conditions: Ebola...